A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom

European Journal of Human Genetics : EJHG
K E HeathM Boxer

Abstract

A genetic diagnostic service for familial hypercholesterolaemia (FH) has been established over the last 4 years in the Clinical Molecular Genetics Laboratory at Great Ormond Street Hospital for Children NHS Trust (GOSH), London. In total there have been 368 referrals; 227 probands and 141 family members, which have come from a number of lipid clinics and from general practitioners. FH is caused by mutations in the low-density lipoprotein receptor gene (LDLR) and these are analysed by SSCP, DNA sequencing and direct assays. The clinically indistinguishable disorder, familial defective apolipoprotein B100 (FDB) is caused by one of three mutations in the apolipoprotein B100 gene (APOB) which are analysed by direct assays. Mutations predicted to be pathogenic were found in 76 probands, 67 in LDLR (23 previously undescribed) and nine in APOB. The mutation detection rate was 53% in paediatric probands, 32% in adults with a 'definite' FH diagnosis (tendon xanthoma positive) and 14% in adults with a 'possible' FH diagnosis (tendon xanthoma negative). The predicted loss of sensitivity that would result from reducing the number of exons tested has been assessed, and a molecular screening strategy suitable for UK patients is proposed. A s...Continue Reading

Citations

Jan 4, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Steve E HumphriesAnthony S Wierzbicki
Apr 13, 2005·Atherosclerosis·M Mert SözenSteve E Humphries
Sep 6, 2003·Atherosclerosis·H A W NeilUNKNOWN Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee
Jul 13, 2007·European Journal of Human Genetics : EJHG·Andrew J P SmithSteve E Humphries
Mar 13, 2012·European Heart Journal·Mohammad Mahdi MotazackerSigrid W Fouchier
Dec 5, 2006·Journal of Medical Genetics·S E HumphriesUNKNOWN Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee
Nov 8, 2002·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Athanasios VergopoulosHerbert Schuster
Dec 14, 2011·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Wai Ping LeeJulian Halcox
Nov 9, 2010·BMJ : British Medical Journal·Aroon D HingoraniLiam Smeeth
Feb 8, 2014·Journal of Lipid Research·Christopher T JohansenRobert A Hegele
Jan 3, 2009·Clinical Biochemistry·Andrew D Laurie, Peter M George
Sep 21, 2007·Atherosclerosis·Ian GrahamUNKNOWN ESC Committee for Practice Guidelines
Jul 11, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Eleftheria Laios, Euridiki Drogari
Jan 25, 2003·Journal of Internal Medicine·J W Stephens, S E Humphries
Sep 4, 2015·European Heart Journal·Ulrich Laufs, Klaus G Parhofer
Jul 18, 2009·Atencion primaria·José M A Lobos BejaranoUNKNOWN Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC)
Nov 6, 2007·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Ian GrahamUNKNOWN European Atherosclerosis Society (EAS)
Mar 1, 2002·Journal of Health Psychology·Victoria SeniorTheresa M Marteau
Jun 25, 2004·American Journal of Medical Genetics. Part a·Theresa MarteauUNKNOWN Genetic Risk Assessment for FH Trial Study Group
Nov 6, 2007·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Ian GrahamUNKNOWN European Heart Network (EHN)
Oct 7, 2004·Circulation·Aldons J LusisGregg C Fonarow
Jan 13, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Steve E HumphriesPhilippa J Talmud
Sep 29, 2004·Circulation·Aldons J LusisGregg C Fonarow
Jan 4, 2003·Stroke; a Journal of Cerebral Circulation·R R HuxleyUNKNOWN Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee
Jan 20, 2005·European Journal of Human Genetics : EJHG·Ainsley J Newson, Steve E Humphries

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.